December 5, 2025 · Form 4 insider transaction
Coliseum Capital Management, LLC bought 191,830 shares of UTI at $25.38 per share, a transaction worth $4.87M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.11 to $25.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.; The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM (the "Separate Account").; Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.; Following the transactions reported herein, CCP holds 3,277,824 shares of Common Stock and the Separate Account holds 693,616 shares of Common Stock.